These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 22337872)
1. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation. Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872 [TBL] [Abstract][Full Text] [Related]
2. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer. Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269 [TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors. Ogi K; Toyota M; Mita H; Satoh A; Kashima L; Sasaki Y; Suzuki H; Akino K; Nishikawa N; Noguchi M; Shinomura Y; Imai K; Hiratsuka H; Tokino T Cancer Biol Ther; 2005 Jul; 4(7):773-80. PubMed ID: 16123600 [TBL] [Abstract][Full Text] [Related]
4. CHFR is important for the first wave of ubiquitination at DNA damage sites. Liu C; Wu J; Paudyal SC; You Z; Yu X Nucleic Acids Res; 2013 Feb; 41(3):1698-710. PubMed ID: 23268447 [TBL] [Abstract][Full Text] [Related]
5. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain. Fukuda T; Kondo Y; Nakagama H PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050 [TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer. Brodie SA; Li G; Harvey D; Khuri FR; Vertino PM; Brandes JC Oncotarget; 2015 Oct; 6(31):30773-86. PubMed ID: 26356822 [TBL] [Abstract][Full Text] [Related]
7. The Stil protein regulates centrosome integrity and mitosis through suppression of Chfr. Castiel A; Danieli MM; David A; Moshkovitz S; Aplan PD; Kirsch IR; Brandeis M; Krämer A; Izraeli S J Cell Sci; 2011 Feb; 124(Pt 4):532-9. PubMed ID: 21245198 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression. Privette LM; González ME; Ding L; Kleer CG; Petty EM Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595 [TBL] [Abstract][Full Text] [Related]
10. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells. Jiang G; Fang H; Shang X; Chen X; Cao F Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594 [TBL] [Abstract][Full Text] [Related]
11. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells. Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102 [TBL] [Abstract][Full Text] [Related]
12. The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest. Madison DL; Stauffer D; Lundblad JR DNA Repair (Amst); 2011 Oct; 10(10):1003-13. PubMed ID: 21840268 [TBL] [Abstract][Full Text] [Related]
13. Chfr is linked to tumour metastasis through the downregulation of HDAC1. Oh YM; Kwon YE; Kim JM; Bae SJ; Lee BK; Yoo SJ; Chung CH; Deshaies RJ; Seol JH Nat Cell Biol; 2009 Mar; 11(3):295-302. PubMed ID: 19182791 [TBL] [Abstract][Full Text] [Related]
14. CHFR: a key checkpoint component implicated in a wide range of cancers. Sanbhnani S; Yeong FM Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584 [TBL] [Abstract][Full Text] [Related]
15. Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. Corn PG; Summers MK; Fogt F; Virmani AK; Gazdar AF; Halazonetis TD; El-Deiry WS Carcinogenesis; 2003 Jan; 24(1):47-51. PubMed ID: 12538348 [TBL] [Abstract][Full Text] [Related]
16. CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells. Wu W; Zhao J; Xiao J; Wu W; Xie L; Xie X; Yang C; Yin D; Hu K Biochem Biophys Res Commun; 2021 Oct; 573():62-68. PubMed ID: 34388456 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Satoh A; Toyota M; Itoh F; Sasaki Y; Suzuki H; Ogi K; Kikuchi T; Mita H; Yamashita T; Kojima T; Kusano M; Fujita M; Hosokawa M; Endo T; Tokino T; Imai K Cancer Res; 2003 Dec; 63(24):8606-13. PubMed ID: 14695171 [TBL] [Abstract][Full Text] [Related]
18. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR). Oberoi J; Richards MW; Crumpler S; Brown N; Blagg J; Bayliss R J Biol Chem; 2010 Dec; 285(50):39348-58. PubMed ID: 20880844 [TBL] [Abstract][Full Text] [Related]
19. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis. He F; Ye B; Wu X; Pan J; Wang J; Wang X BMC Gastroenterol; 2023 Apr; 23(1):114. PubMed ID: 37024798 [TBL] [Abstract][Full Text] [Related]
20. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. Kang D; Chen J; Wong J; Fang G J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]